ASO Author Reflections: MRI-Derived Biomarker to Select Optimal Treatment for Esophageal Cancer Patients

被引：2
|
作者：
Hayano, Koichi [1 ]
Hirata, Atsushi [1 ]
Matsubara, Hisahiro [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / 08期
关键词：
D O I：
10.1245/s10434-020-08298-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3090 / 3091
页数：2
相关论文
共 50 条
  • [31] ASO Author Reflections: Current State of Surgical Sarcopenia in Esophageal Cancer
    Uemura, Shion
    Shichinohe, Toshiaki
    Hosokawa, Masao
    Hirano, Satoshi
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S670 - S671
  • [32] ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer
    Yu Ohkura
    Annals of Surgical Oncology, 2020, 27 : 660 - 661
  • [33] ASO Author Reflections: Margin Positivity Following Esophageal Cancer Resection is Associated with Treatment Decisions
    Cary Jo R. Schlick
    David J. Bentrem
    Annals of Surgical Oncology, 2020, 27 : 1508 - 1509
  • [34] ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer
    Ohkura, Yu
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (03) : 660 - 661
  • [35] ASO Author Reflections: Margin Positivity Following Esophageal Cancer Resection is Associated with Treatment Decisions
    Schlick, Cary Jo R.
    Bentrem, David J.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1508 - 1509
  • [36] MRI-derived radiomics to select patients with high-risk prostate cancer for adjuvant radiotherapy
    Bourbonne, V.
    Vallieres, M.
    Lucia, F.
    Fournier, G.
    Valeri, A.
    Visvikis, D.
    Tissot, V.
    Pradier, O.
    Hatt, M.
    Schick, U.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S451 - S452
  • [37] ASO Author Reflections: CXCR7 and CXCL12 Expression as Biomarker in Patients with Esophageal Adenocarcinoma
    Goto, Masakazu
    Liu, Mingyao
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 4952 - 4952
  • [38] ASO Author Reflections: CXCR7 and CXCL12 Expression as Biomarker in Patients with Esophageal Adenocarcinoma
    Masakazu Goto
    Mingyao Liu
    Annals of Surgical Oncology, 2021, 28 : 4952 - 4952
  • [39] ASO Author Reflections: Fibrinogen and Albumin Score Validated as a Prognostic Factor to Refine the Treatment Strategy for Esophageal Cancer Patients
    Matsuda, Satoru
    Takeuchi, Hiroya
    Kawakubo, Hirofumi
    Takemura, Ryo
    Maeda, Yusuke
    Hirata, Yuki
    Kaburagi, Takuji
    Egawa, Tomohisa
    Nishi, Tomohiko
    Ogura, Masaharu
    Miyasho, Taku
    Okamura, Akihiko
    Mayanagi, Shuhei
    Fukuda, Kazumasa
    Nakamura, Rieko
    Irino, Tomoyuki
    Wada, Norihito
    Kitagawa, Yuko
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 886 - 887
  • [40] ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer
    Wang, H. H.
    Plukker, J. Th. M.
    Hospers, G. A. P.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (07) : 3961 - 3962
12345